TuisMDT • NYSE
add
Medtronic PLC
Vorige sluiting
$82,68
Dagwisseling
$80,51 - $82,49
Jaarwisseling
$75,96 - $92,68
Markkapitalisasie
103,43 mjd USD
Gemiddelde volume
6,11 m
P/V-verhouding
24,61
Dividend-opbrengs
3,47%
Primêre beurs
NYSE
In die nuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
(USD) | Okt. 2024info | J/J-verandering |
---|---|---|
Inkomste | 8,40 mjd | 5,25% |
Bedryfskoste | 3,78 mjd | 2,30% |
Netto inkomste | 1,27 mjd | 39,71% |
Netto winsgrens | 15,11 | 32,66% |
Wins per aandeel | 1,26 | 0,80% |
EBITDA | 2,36 mjd | 6,70% |
Effektiewe belastingkoers | 18,01% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
(USD) | Okt. 2024info | J/J-verandering |
---|---|---|
Kontant en korttermynbeleggings | 7,99 mjd | 3,30% |
Totale bates | 90,04 mjd | -0,05% |
Totale aanspreeklikheid | 41,33 mjd | 7,51% |
Totale ekwiteit | 48,72 mjd | — |
Uitstaande aandele | 1,28 mjd | — |
Prys om te bespreek | 2,19 | — |
Opbrengs op bates | 4,68% | — |
Opbrengs op kapitaal | 5,50% | — |
Kontantvloei
Netto kontantverandering
(USD) | Okt. 2024info | J/J-verandering |
---|---|---|
Netto inkomste | 1,27 mjd | 39,71% |
Kontant van bedrywe | 958,00 m | 44,93% |
Kontant van beleggings | -345,00 m | 18,63% |
Kontant van finansiering | -534,00 m | -493,33% |
Netto kontantverandering | 83,00 m | 396,43% |
Beskikbare kontantvloei | 748,25 m | 16,23% |
Meer oor
Medtronic plc is an American-Irish medical device company. The company's operational and executive headquarters are in Minneapolis, Minnesota, and its legal headquarters are in Ireland due to its acquisition of Irish-based Covidien in 2015. While it primarily operates in the United States, it operates in more than 150 countries and employs over 90,000 people. It develops and manufactures healthcare technologies and therapies. It is one of the biggest medical tech companies in the world and is currently the largest medical device company in the world by revenue.
Medtronic's pioneering innovations have transformed healthcare through ground-breaking medical devices. The company has developed several world-first technologies since its inception, including wearable and implantable pacemakers, the implantable cardioverter defibrillator, and remote monitoring systems. They also created breakthrough solutions in diabetes care with the first 24-hour automated insulin delivery, deep brain stimulation, and miniaturized devices like the world's smallest pacemaker and spinal cord stimulator. Wikipedia
Gestig
1949
Webwerf
Werknemers
95 000